Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 364, Issue 7, Pages 603-615
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2011-02-17
DOI
10.1056/nejmoa1007374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage
- (2010) Hossein Nazari et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels
- (2010) Joo Yong Lee et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Avastin as monotherapy for retinopathy of prematurity
- (2010) Helen A. Mintz-Hittner JOURNAL OF AAPOS
- Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity
- (2010) Janice C. Law et al. JOURNAL OF AAPOS
- Effects and Complications of Bevacizumab Use in Patients with Retinopathy of Prematurity: A Multicenter Study in Taiwan
- (2010) Wei-Chi Wu et al. OPHTHALMOLOGY
- AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY
- (2010) KIMBERLY A. DRENSER et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- TREATMENT OF TYPE 1 RETINOPATHY OF PREMATURITY WITH INTRAVITREAL BEVACIZUMAB (AVASTIN)
- (2010) PAOLA DORTA et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Paradoxical vascular–fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity
- (2009) L C Zepeda-Romero et al. EYE
- ANTIANGIOGENIC THERAPY WITH INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY
- (2009) HUGO QUIROZ-MERCADO et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- OFF-LABEL USE OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR SALVAGE TREATMENT IN PROGRESSIVE THRESHOLD RETINOPATHY OF PREMATURITY
- (2009) GEETA A. LALWANI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
- (2008) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreous Bevacizumab as Anti–Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Morphologic Study
- (2008) Lingkun Kong ARCHIVES OF OPHTHALMOLOGY
- Retinopathy of prematurity in the United States
- (2008) E. M. Lad et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study
- (2008) S Kusaka et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control
- (2008) Clare Gilbert EARLY HUMAN DEVELOPMENT
- Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity
- (2008) Shigeru Honda et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intraocular inflammation following intravitreal injection of bevacizumab
- (2008) Sophie J. Bakri et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) FOR TREATMENT OF STAGE 3 RETINOPATHY OF PREMATURITY IN ZONE I OR POSTERIOR ZONE II
- (2008) HELEN A. MINTZ-HITTNER et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now